Soumit K. Basu, Binaish Khan, Francis Payumo, Robert Wan, E. Gabriela Chiorean, Zhubin Gahvari, Joel R. Hecht, Michael E. Hurwitz, Rom S. Leidner, Heinz-Josef Lenz, Meredith Pelster, Salman Rafi Punekar, Adam Jacob Schoenfeld, Dan Zhao, Dirk Nagorsen. "A phase I study of AFNT-211, autologous CD4
            <sup>+</sup>
            and CD8
            <sup>+</sup>
            T cells engineered to express a high avidity HLA-A*11:01-restricted, KRAS G12V-specific transgenic TCR; CD8α/β coreceptor; and FAS-41BB switch receptor in patients with advanced or metastatic solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps2678